(Q51749731)

English

A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.

scientific article published on 8 June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17578788

A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa. (English)

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17578788

anti-retroviral agent

0 references

0 references

lactic acidosis

1 reference

based on heuristic

inferred from title

author name string

Bolhaar MG

1

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17578788

Karstaedt AS

2

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17578788

language of work or name

0 references

publication date

8 June 2007

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17578788

Clinical Infectious Diseases

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17578788

45

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17578788

2

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17578788

254-260

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17578788

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Mitochondrial toxicity and HIV therapy

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Hyperlactataemia syndromes associated with HIV therapy

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Lactic acidosis in HIV infected patients: a systematic review of published cases

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons.

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

The influence of sex on pharmacokinetics

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir or zidovudine

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Hyperlactatemia syndromes in people with HIV infection

1 reference

https://api.crossref.org/works/10.1086%2F518976

21 January 2018

Identifiers

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17578788

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17578788

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51749731&oldid=1523488806"